Whatever you've got to say about Google, it can't hear you over the sound of it banking $85m a day in pure profit • The Register
- TECHNOLOGY
- February 5, 2019
Royal Society of Medicine convenes global Covid-19 clinical conference: An international Covid-19 conference to consolidate key clinical learning from across the globe will take place online on Monday 27 July from 16.00 hrs to 18.15 hrs (UK time). Hosted by the Royal Society of Medicine, the conference will draw together an international faculty of leading clinicians
READ MOREThis RSM Covid-19 webinar takes place today at 12.30pm – 1.00pm : COVID-19 Series: Caring for our children in a time of COVID-19 From the uncertainties around transmission and the pathophysiological differences between children and adults, to the impact of lockdown on learning and mental health, the impact of COVID-19 on children is broad and uncertain.
READ MORECOVID-19 Series: Vaccines Episode 20 will be broadcast on zoom on Tue 9 Jun 2020 from 12:30pm to 1:00pm. Key speakers: Professor Robin Shattock, Head of Mucosal Infection and Immunity at Imperial College London. Dr Thomas Breuer, Chief Medical Officer at GSK Vaccines. A safe and effective vaccine against COVID-19 is generally regarded as the only way
READ MOREOn Thursday 17 January five young doctors will compete for the coveted title of Wesleyan RSM trainee of the year. Meet the finalist | Dr Katie Samuel RSM Orthopaedics Section Presentation title: National practice of midstream urine testing preoperatively for elective orthopaedics – Is it worth the resources? A career with a breadth of skills Anaesthesia is
READ MOREMeet the Finalist | Dr Egho Ireo RSM Digital Health Section Presentation title: The Yo-band and Yo-bot: Wearable technology for managing mental health. Training update After studying medicine at the University of Bristol, Dr Egho Ireo is currently taking a year out of training between the foundation programme and specialty training. During this time she
READ MOREMeet the finalist | Dr Jonathan Evans RSM Coloproctology Section Presentation title: The Nrf2 inhibitor Brusatol is a potent antitumour agent, and enhances irinotecan cytotoxicity, in an orthotopic mouse model of colorectal cancer. Focus on colorectal cancer Currently a specialist trainee in general surgery, with a sub-specialty interest in colorectal, Dr Jonathan Evans studied medicine at the University of Liverpool.
READ MORE